Abstract:Introduction Allopurinol is a hypouricemic drug that has been prescribed since 1963. It is one of the most common drugs that induce Severe Cutaneous Adverse Reactions (SCARs), namely Stevens Johnson syndrome (SJS)/Lyell syndrome (LS) and DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms). In our hospital series, we report cases of SCARs attributed to allopurinol in order to sensitize prescribers to the risk of its misuse. Patients and methods We carried out a retrospective study from 2011 to 2021 of patients hospitalized at our dermatology department for SCARs induced by allopurinol. Imputability was confirmed by the French methodology of Bégaud et al. Results We identified 31 cases. The median age was 63 years (26–83). The sex-ratio (M/F) was 0.34. Twenty-two point five percent of patients were being followed for chronic renal disease. Allopurinol was prescribed in 77.4% cases for laboratory indications of asymptomatic hyperuricemia. Combined use with a thiazide diuretic was found in 51.6% of patients. The clinical forms were: 21 DRESS syndrome, 5 LS, 2 overlap syndrome and 3 SJS. The median time to onset of clinical signs was 4 days to 5 weeks for SJS/LS and 2 to 8 weeks for DRESS. Complications were as follows: renal failure (48.3%), hepatic cytolysis (51.6%), electrolyte imbalance in (54.8%), severe sepsis (16.6%) and corneal ulcer (6.4%). Major hypereosinophilia was noted in 48.3% of cases and was significantly associated with hepatic cytolysis ( P = 0.014). Five patients required a stay in the intensive care unit, with death occurring in 12.9%. Conclusion Despite its capacity to cause life-threatening SCARs, allopurinol continues to be prescribed in most cases of asymptomatic hyperuricemia. Such misuse in terms of indication and follow-up warrants the raising of physicians' awareness concerning the benefit/risk ratio. Résumé Introduction L'allopurinol est un hypo-uricémiant pourvoyeur de toxidermies graves parfois mortelles à savoir le syndrome de Stevens Johnson (SSJ)/Lyell (SL) et le DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms) syndrome. Nous rapportons à travers notre série hospitalière les effets indésirables graves cutanés et viscéraux imputés à l'allopurinol afin de sensibiliser les prescripteurs au risque de son mésusage. Patients et méthodes Étude rétrospective allant de 2011 à 2021 des patients hospitalisés pour toxidermie grave causée par l'allopurinol dans notre département de dermatologie. L'imputabilité à l'allopurinol était confirmée par la méthodologie française de Bégaud et al. Résultats Nous avons recensé 31 cas. L'âge médian est de 63 ans (26–83). Le sex-ratio (H/F) : 0,34. Sept patients (22,5 %) étaient suivis pour maladie rénale chronique. L'allopurinol était prescrit chez 77,4 % devant une hyper uricémie biologique et asymptomatique. L'association à un diurétique thiazidique était retrouvée chez 51,6 %. Les formes cliniques étaient: 21 syndromes de DRESS, 5 SL, 2 SC et 3 SSJ. Le délai médian de survenue des signes cliniques était de 4 jours à 5 semaines pour le SSJ/SL et de 2 à 8 semaines pour le DRESS. Les complications étaient: insuffisance rénale fonctionnelle chez 48,3 %, cytolyse hépatique chez 51,6 %, des troubles hydro-électrolytiques chez 54,8 %, un sepsis grave chez 16,6 % et un ulcère de cornée chez 6,4%. Une hyper éosinophilie majeure a été retrouvée chez 48,3 % qui est significativement associée à une atteinte hépatique (valeur p = 0,014). Cinq patients ont nécessité un séjour en réanimation avec décès chez 12,9 %. Conclusion L'allopurinol est pourvoyeur de toxidermies graves pouvant engager le pronostic vital. Il est prescrit dans la plupart des cas devant une hyper uricémie asymptomatique. Cette mauvaise utilisation en termes d'indication et de suivi justifie une sensibilisation des médecins à bien mesurer le bénéfice/risque.

DRESS à la loxapine confirmé par patch test suivi d’une récidive évitable sous clozapine

Unravelling cases of clozapine-related Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) in patients reported otherwise: A systematic review

Clozapine-related drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a systematic review

Loxapine in patient with clozapine-resistant psychosis

Antipsychotics Induced Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome: Literature Review and a Report of a Suspected Case Related to Chlorpromazine

Loxapine in the Treatment of Manic and Psychotic Symptoms in an Individual Intolerant to Multiple Mood-Stabilizing and Antipsychotic Medications

Antipsychotic-Related DRESS Syndrome: Analysis of Individual Case Safety Reports of the WHO Pharmacovigilance Database

Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome with Multiple Drugs (Leflunomide and Cefuroxime): A Case Report

Drug reaction with eosinophilia and systemic symptoms (DRESS): an original multisystem adverse drug reaction. Results from the prospective RegiSCAR study

DRESS Syndrome: Renal Involvement in Two Cases - A Comprehensive Analysis and Literature Review of Improved Diagnosis and Treatment

Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?

Toxic epidermal necrolysis, DRESS, AGEP: Do overlap cases exist?

Patch testing is an effective method for the diagnosis of carbamazepine-induced drug reaction, eosinophilia and systemic symptoms (DRESS) syndrome in an 8-year-old girl

Syndrome inflammatoire de reconstitution immune précédant l’administration du deuxième cycle de cladribine chez une SEP-RR

Management of Psychotropic Drug-Induced DRESS Syndrome: A Systematic Review

Recurrent high creatine kinase levels under clozapine treatment - a case report assessing a suspected adverse drug reaction

Amoxicillin and lamotrigine-induced DRESS syndrome: A case report

A Retrospective Pilot Study to Develop a Pharmacological Causality Algorithm for Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)

DRESS syndrome with mild manifestations as a diagnostic and therapeutic problem: case report

Allopurinol induced severe cutaneous adverse reactions: Vigilance of prescription (31 cases)

A Rare Presentation of an Adverse Reaction to Minocycline